Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma
CEC.6
NCT00887146
 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Brain |
Dr. Laura Masucci
Diane Trudel
514-890-8000 poste 11181
|
A Phase III Trial of Stereotactic Radiosurgery Compared With Whole Brain Radiotherapy (WBRT) for 5-15 Brain Metastases
CE.7
NCT03550391
Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Brain |
Dr. David Roberge
Mom Phat
514-890-8000 poste 11171
|
Phase III Trial of Observation Versus Irradiation for a Gross Totally Resected Grade II Meningioma
NRG-BN003
NCT03180268
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Bassam Abdulkarim
Ginette Ricard
514-934-1934 poste 43186
|
A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy
Orbus OT-15-0011
NCT02796261
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL NEUROLOGIQUE DE MONTREAL
|
Brain |
Dr. Kevin Petrecca
Gabriele Riva
514-398-6907
|
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme
INTRAGO II
NCT02685605
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
HOPITAL NEUROLOGIQUE DE MONTREAL
|
Brain |
Dr. Kevin Petrecca
Gabriele Riva
514-398-6907
|
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
BN001
NCT02179086
Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Brain |
Dr. Nathalie Lessard
Josée Allard
418-525-4444 poste 16730
|
A Phase II Study in Relapsing Glioblastoma of Intraarterial Concurrent Chemoradiation Therapy Using IA Carboplatin
2018-2452
NCT03672721
Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Brain |
Dr. David Fortin
Marie-Andrée Roy
819-346-1110 poste 13895
|
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
BN001
NCT02179086
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. Valérie Panet-Raymond
Marie-Claude Joncas
514-934-1934 poste 34906
|
Metformin and Neo-adjuvant Temozolomide and Hypofractionated Accelerated Limited-margin Radiotherapy Followed by Adjuvant Temozolomide in Patients With Glioblastoma Multiforme
MUHC ID: 4315 (M-HARTT STUDY)
NCT02780024
Recruiting
|
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN
|
Brain |
Dr. George Shenouda
Marianna Perna
514-934-1934 poste 43191
|
Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
GBM AGILE
NCT03970447
Recruiting
|
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT
|
Brain |
Dr. David Mathieu
Mégane Lebel
819-346-1110 poste 14138
|
Groupe d'étude en oncologie du Québec